Rare Disease Genetic
Testing: Introduction
·
More than 7000 types of rare diseases affect more than 30
million people in the U.S. alone. Approximately 80% of the rare diseases are
found to be genetic.
·
Genetic testing is an advanced diagnostic tool that not only
helps to identify the exact disease manifestations but also determine the
underlying causes of genetic disorders
·
Genetic testing offers various benefits including confirming a
diagnosis, understanding the cause of unexplained symptoms, and identifying
treatment options including clinical trials
Read Report Overview: https://www.transparencymarketresearch.com/rare-disease-genetic-testing-market.html
Key Drivers and
Restraints of Global Rare Disease Genetic Testing Market
·
Growth of molecular biology has transformed the diagnosis and
treatment of diseases. Modern test methods, based on the detection of DNA and
RNA, offer several advantages over traditional methods for the detection of
diseases. New procedures can detect viruses, bacteria, and genetic variations
faster and much more accurately.
·
New innovative technologies such as RT-PCR and sequencing are
available in the market, which provide a comparatively less expensive method of
diagnosis, prognosis, and therapy selection in patients throughout their
treatment plan. This helps physicians to frame appropriate therapeutic regimes
for patients suffering from disease.
Request
a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80353
·
Thus, continuous improvement in the technology is expected to
drive the global rare disease genetic testing market during the forecast period
·
Prevalence of autoimmune disease throughout modern societies has
been increasing at a steady pace for the last few decades
·
According to Autoimmunity Reviews, autoimmune diseases are a
leading cause of death in the U.S. among young and middle aged people
·
For instance, according to International Journal of Recent
Scientific Research, the incidence of celiac diseases has increased in
countries such as Scotland and Canada in the last 60 years
·
Thus an increase in the incidence of these diseases is a key
factor that is estimated to propel the global rare disease genetic testing
market during the forecast period
Request for Analysis of COVID19
Impact on Rare Disease Genetic Testing Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80353
Next-generation
Sequencing to Offer Lucrative Growth Opportunities
·
The global rare disease genetic testing market can be segmented
based on technology, specialty, indication, end-user, and region
·
In terms of technology, the global rare disease genetic testing
market can be classified into next generation sequencing (whole exome
sequencing and whole genome sequencing), array technology, PCR - based testing,
FISH, sanger sequencing, and karyotyping
Request
For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80353
·
Based on specialty, the market can be segmented into molecular
genetic tests, chromosomal genetic tests, and biochemical genetic tests. In
terms of indication, the global rare disease genetic testing market can be
segmented into neurological disorders, immunological disorders, hematology
diseases, endocrine & metabolism diseases, cancer, musculoskeletal
disorders, cardiovascular disorders, dermatology diseases, and other rare diseases.
·
Based on end-user, the global market can be categorized into
research laboratories & CROs, hospitals & clinics, and diagnostic
laboratories
Pre-book Rare Disease Genetic
Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80353<ype=S
North America &
Europe to Dominate Rare Disease Genetic Testing Market
·
The global rare disease genetic testing market can be segmented
into North America, Europe, Asia Pacific, Latin America, and Middle East &
Africa
·
High prevalence of different types of cancer and rising
geriatric population in the region are some factors augmenting the market in
North America. Rise in awareness regarding disease prevention and increasing
adoption of advanced technological platforms for the development of various
diagnostic tests are some factors boosting the market in Europe.
More Trending
Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/presence-of-large-insulin-dependent-diabetic-population-expand-avenue-in-self-injection-device-market-pen-injectors-to-account-for-sizable-revenue-share-says-tmr-301260639.html
https://www.prnewswire.com/news-releases/overwhelming-cases-of-drug-driving-accidents-underscores-growth-in-roadside-drug-testing-devices-market-authorities-consider-use-of-technology-to-support-testing-tmr-301266637.html
https://www.prnewswire.com/news-releases/technological-advancements-like-3d-printing-and-an-increase-in-the-number-of-amputations-due-to-various-factors-will-serve-as-growth-pillars-for-the-prosthetics-market-says-tmr-301271549.html
About Us
Transparency Market Research is a global market intelligence
company providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of analysts, researchers, and consultants use proprietary data sources and
various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
